ProteinSimple is part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH). We're rethinking protein tools and helping thousands of researchers around the world resolve their protein analysis problems so they can reveal new insight into proteins and their role in disease. Our wide-ranging portfolio of tools includes everything from immunoassay systems that quantify protein expression to systems that probe the structure and purity of protein-based therapeutics.
ProteinSimple is now a brand in the Bio-Techne family of brands that includes R&D Systems, Novus Biologicals and Tocris. As a company, Bio-Techne has developed, manufactured and sold biotechnology products, clinical calibrators and controls, and consumables for protein analysis„and now analytical instrumentation and consumables through ProteinSimple. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.
- Company Name:Proteinsimple
(View Trends)
-
Headquarters: (View Map)San Jose, CA, United States
-
Biotechnology
-
200 - 500 employees
- 1135724 Global Rank
- 503772 United States
- 135 K Estimated Visits
-
Search54.30%
-
Direct37.22%
-
Referrals8.03%
-
Mail0.31%
-
Social0.08%
-
Display0.07%
-
36.04%
-
7.14%
-
4.71%
- United States 69.8%
- Breast
- Susan G. Komen Breast Cancer Foundation
- 10 SDKs
- App Url: https://itunes.apple.com/app/proteinsimple/id1304710493
- App Support: https://www.proteinsimple.com
- Genre: Business
- Bundle ID: com.proteinsimple.milo
- App Size: 841 M
- Version: 1.1
- Release Date: November 2nd, 2017
- Update Date: November 2nd, 2017
Description:
Step into our virtual lab and experience Milo for yourself. For mobile viewing, this video requires a virtual reality kit, such as Google Cardboard.
Milo™ is the world's first Single-Cell Western platform. In one 4-hour experiment, Milo can measure protein expression in ~1,000 single cells. Count and quantify subpopulations of cells that can’t be resolved with conventional Westerns.
Let Milo help you unlock the single-cell proteome with protein heterogeneity profiling, RNA-seq validation, and simplified phospho-flow studies.
-
Native0.00%
-
Standard100.00%